FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:546-553 August 7, 2003 Number 6 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Krag, D. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation.

Methods From March 1998 to December 1999, we randomly assigned 516 patients with primary breast cancer in whom the tumor was less than or equal to 2 cm in diameter either to sentinel-node biopsy and total axillary dissection (the axillary-dissection group) or to sentinel-node biopsy followed by axillary dissection only if the sentinel node contained metastases (the sentinel-node group).

Results The number of sentinel nodes found was the same in the two groups. A sentinel node was positive in 83 of the 257 patients in the axillary-dissection group (32.3 percent), and in 92 of the 259 patients in the sentinel-node group (35.5 percent). In the axillary-dissection group, the overall accuracy of the sentinel-node status was 96.9 percent, the sensitivity 91.2 percent, and the specificity 100 percent. There was less pain and better arm mobility in the patients who underwent sentinel-node biopsy only than in those who also underwent axillary dissection. There were 15 events associated with breast cancer in the axillary-dissection group and 10 such events in the sentinel-node group. Among the 167 patients who did not undergo axillary dissection, there were no cases of overt axillary metastasis during follow-up.

Conclusions Sentinel-node biopsy is a safe and accurate method of screening the axillary nodes for metastasis in women with a small breast cancer.

Source Information

From the Divisions of Senology (U.V., A.L., S.Z., V.G., M.I., P.V., R.G.), Nuclear Medicine (G.P., C.D.), Pathology (G.V., G.R.), Epidemiology (C.R., P.M.), and Anaesthesiology (F.D.), European Institute of Oncology; and the University of Milan School of Medicine (G.V.) — both in Milan, Italy.

Address reprint requests to Dr. Umberto Veronesi at the Istituto Europeo di Oncologia, Via G. Ripamonti 435, 20141 Milan, Italy, or at umberto.veronesi{at}ieo.it.

Full Text of this Article

Related Letters:

Sentinel-Node Biopsy in Breast Cancer
Badwe R. A., Thorat M. A., Parmar V. V., De Salvo G. L., Del Bianco P., Zavagno G., Munster A. M., McMasters K. M., Veronesi U., Maisonneuve P., Krag D., Ashikaga T.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:1968-1971, Nov 13, 2003. Correspondence

This article has been cited by other articles:

• Kootstra, J., Hoekstra-Weebers, J. E. H. M., Rietman, H., de Vries, J., Baas, P., Geertzen, J. H. B., Hoekstra, H. J. (2008). Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study. Ann. Surg. Oncol. 15: 2533-2541 [Abstract] [Full Text]  
• Perhavec, A., Besic, N., Hocevar, M., Zgajnar, J. (2008). Touch Imprint Cytology of the Sentinel Lymph Nodes Might Not Be Indicated in Early Breast Cancer Patients with Ultrasonically Uninvolved Axillary Lymph Nodes. Ann. Surg. Oncol. 15: 2257-2262 [Abstract] [Full Text]  
• Bear, H. D. (2008). Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None. JCO 26: 3483-3484 [Full Text]  
• Olson, J. A. Jr, McCall, L. M., Beitsch, P., Whitworth, P. W., Reintgen, D. S., Blumencranz, P. W., Leitch, A. M., Saha, S., Hunt, K. K., Giuliano, A. E. (2008). Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011. JCO 26: 3530-3535 [Abstract] [Full Text]  
• Crane-Okada, R., Wascher, R. A., Elashoff, D., Giuliano, A. E. (2008). Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer. Ann. Surg. Oncol. 15: 1996-2005 [Abstract] [Full Text]  
• Altgassen, C., Hertel, H., Brandstadt, A., Kohler, C., Durst, M., Schneider, A. (2008). Multicenter Validation Study of the Sentinel Lymph Node Concept in Cervical Cancer: AGO Study Group. JCO 26: 2943-2951 [Abstract] [Full Text]  
• Poletti, P., Fenaroli, P., Milesi, A., Paludetti, A., Mangiarotti, S., Virotta, G., Candiago, E., Bettini, A., Caremoli, E. R., Labianca, R., Tondini, C. (2008). Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol 0: mdn393v1-mdn393 [Abstract] [Full Text]  
• Shimazu, K., Tamaki, Y., Taguchi, T., Tsukamoto, F., Kasugai, T., Noguchi, S. (2008). Intraoperative Frozen Section Analysis of Sentinel Lymph Node in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann. Surg. Oncol. 15: 1717-1722 [Abstract] [Full Text]  
• Yang, S. H., Yang, K. H., Li, Y. P., Zhang, Y. C., He, X. D., Song, A. L., Tian, J. H., Jiang, L., Bai, Z. G., He, L. F., Liu, Y. L., Ma, B. (2008). Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials. Ann Oncol 19: 1039-1044 [Abstract] [Full Text]  
• Samphao, S., Eremin, J. M., El-Sheemy, M., Eremin, O. (2008). Management of the Axilla in Women With Breast Cancer: Current Clinical Practice and a New Selective Targeted Approach. Ann. Surg. Oncol. 15: 1282-1296 [Abstract] [Full Text]  
• Intra, M., Garcia-Etienne, C. A., Renne, G., Trifiro, G., Rotmensz, N., Gentilini, O. D., Galimberti, V., Sagona, A., Mattar, D., Sangalli, C., Gatti, G., Luini, A., Veronesi, U. (2008). When Sentinel Lymph Node is Intramammary. Ann. Surg. Oncol. 15: 1304-1308 [Abstract] [Full Text]  
• Tan, L. K., Giri, D., Hummer, A. J., Panageas, K. S., Brogi, E., Norton, L., Hudis, C., Borgen, P. I., Cody, H. S. III (2008). Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-Up. JCO 26: 1803-1809 [Abstract] [Full Text]  
• van der Ploeg, I. M. C., Kroon, B. B. R., Antonini, N., Olmos, R. A. V., Rutgers, E. J. T., Nieweg, O. E. (2008). Axillary and Extra-axillary Lymph Node Recurrences after a Tumor-Negative Sentinel Node Biopsy for Breast Cancer Using Intralesional Tracer Administration. Ann. Surg. Oncol. 15: 1025-1031 [Abstract] [Full Text]  
• Fink, A. M., Lass, H., Hartleb, H., Jurecka, W., Salzer, H., Steiner, A. (2008). S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer. Ann. Surg. Oncol. 15: 848-853 [Abstract] [Full Text]  
• Somasundaram, S. K., Chicken, D. W., Keshtgar, M. R. S. (2008). Detection of the sentinel lymph node in breast cancer. Br Med Bull 0: ldm032v1-15 [Abstract] [Full Text]  
• Arora, N., Martins, D., Huston, T. L., Christos, P., Hoda, S., Osborne, M. P., Swistel, A. J., Tousimis, E., Pressman, P. I., Simmons, R. M. (2008). Sentinel Node Positivity Rates With and Without Frozen Section for Breast Cancer. Ann. Surg. Oncol. 15: 256-261 [Abstract] [Full Text]  
• Goyal, A., Newcombe, R. G., Chhabra, A., Mansel, R. E. (2008). Morbidity in Breast Cancer Patients with Sentinel Node Metastases Undergoing Delayed Axillary Lymph Node Dissection (ALND) Compared with Immediate ALND. Ann. Surg. Oncol. 15: 262-267 [Abstract] [Full Text]  
• Nathanson, S. D., Burke, M., Slater, R., Kapke, A. (2007). Preoperative Identification of the Sentinel Lymph Node in Breast Cancer. Ann. Surg. Oncol. 14: 3102-3110 [Abstract] [Full Text]  
• Yamauchi, C., Mitsumori, M., Sai, H., Imagunbai, T., Negoro, Y., Sasaki, Y., Hiraoka, M., Shikama, N., Sasaki, S., Takegawa, H., Inoue, T., Teshima, T. (2007). Patterns of Care Study of Breast-conserving Therapy in Japan: Comparison of the Treatment Process between 1995 1997 and 1999 2001 Surveys. Jpn J Clin Oncol 0: hym096v1-7 [Abstract] [Full Text]  
• Colleoni, M., Rotmensz, N., Maisonneuve, P., Sonzogni, A., Pruneri, G., Casadio, C., Luini, A., Veronesi, P., Intra, M., Galimberti, V., Torrisi, R., Andrighetto, S., Ghisini, R., Goldhirsch, A., Viale, G. (2007). Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 18: 1632-1640 [Abstract] [Full Text]  
• Gervasoni, J. E. Jr., Sbayi, S., Cady, B. (2007). Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.. Ann. Surg. Oncol. 14: 2443-2462 [Abstract] [Full Text]  
• Nos, C., Lesieur, B., Clough, K. B., Lecuru, F. (2007). Blue Dye Injection in the Arm in Order to Conserve the Lymphatic Drainage of the Arm in Breast Cancer Patients Requiring an Axillary Dissection. Ann. Surg. Oncol. 14: 2490-2496 [Abstract] [Full Text]  
• Bevilacqua, J. L. B., Kattan, M. W., Fey, J. V., Cody, H. S. III, Borgen, P. I., Van Zee, K. J. (2007). Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation. JCO 25: 3670-3679 [Abstract] [Full Text]  
• Nakagawa, T., Martinez, S. R., Goto, Y., Koyanagi, K., Kitago, M., Shingai, T., Elashoff, D. A., Ye, X., Singer, F. R., Giuliano, A. E., Hoon, D. S.B. (2007). Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes. Clin. Cancer Res. 13: 4105-4110 [Abstract] [Full Text]  
• Langer, I., Guller, U., Koechli, O. R., Berclaz, G., Singer, G., Schaer, G., Fehr, M. K., Hess, T., Oertli, D., Bronz, L., Schnarwyler, B., Wight, E., Uehlinger, U., Infanger, E., Burger, D., Zuber, M., for the Swiss Multicenter Sentinel Lymph Node Stud, (2007). Association of the Presence of Bone Marrow Micrometastases with the Sentinel Lymph Node Status in 410 Early Stage Breast Cancer Patients: Results of the Swiss Multicenter Study. Ann. Surg. Oncol. 14: 1896-1903 [Abstract] [Full Text]  
• Nathanson, S. D., Grogan, J. K., DeBruyn, D., Kapke, A., Karvelis, K. (2007). Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure. Ann. Surg. Oncol. 14: 1629-1637 [Abstract] [Full Text]  
• Gentilini, O., Chagas, E., Zurrida, S., Intra, M., De Cicco, C., Gatti, G., Silva, L., Renne, G., Cassano, E., Veronesi, U. (2007). Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer. The Oncologist 12: 512-515 [Abstract] [Full Text]  
• Barros, A. C. S. D., Barros, M. A. C., Andrade, F. E., Mori, L. J., Costa, P. A., Sheng, P. Y., Pelizon, C. H. T. (2007). Combined Radioguided Nonpalpable Lesion Localization and Sentinel Lymph Node Biopsy for Early Breast Carcinoma. Ann. Surg. Oncol. 14: 1472-1477 [Abstract] [Full Text]  
• Dauphine, C. E., Haukoos, J. S., Vargas, M. P., Isaac, N. M., Khalkhali, I., Vargas, H. I. (2007). Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy. Ann. Surg. Oncol. 14: 1014-1019 [Abstract] [Full Text]  
• Veronesi, U, De Cicco, C, Galimberti, V., Fernandez, J., Rotmensz, N, Viale, G, Spano, G, Luini, A, Intra, M, Veronesi, P, Berrettini, A, Paganelli, G (2007). A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 18: 473-478 [Abstract] [Full Text]  
• Smidt, M. L., Strobbe, L. J. A., Groenewoud, H. M. M., der Wilt, G. J., Van Zee, K. J., Wobbes, T. (2007). Can Surgical Oncologists Reliably Predict the Likelihood for Non-SLN Metastases in Breast Cancer Patients?. Ann. Surg. Oncol. 14: 615-620 [Abstract] [Full Text]  
• Lelievre, L., Houvenaeghel, G., Buttarelli, M., Brenot-Rossi, I., Huiart, L., Tallet, A., Tarpin, C., Jacquemier, J. (2007). Value of the Sentinel Lymph Node Procedure in Patients With Large Size Breast Cancer. Ann. Surg. Oncol. 14: 621-626 [Abstract] [Full Text]  
• Shimizu, C., Ando, M., Kouno, T., Katsumata, N., Fujiwara, Y. (2007). Current Trends and Controversies over Pre-operative Chemotherapy for Women with Operable Breast Cancer. Jpn J Clin Oncol 0: hyl122v1-8 [Abstract] [Full Text]  
• Gilligan, M. A., Neuner, J., Sparapani, R., Laud, P. W., Nattinger, A. B. (2007). Surgeon Characteristics and Variations in Treatment for Early-Stage Breast Cancer. Arch Surg 142: 17-22 [Abstract] [Full Text]  
• Nakagawa, T., Huang, S. K., Martinez, S. R., Tran, A. N., Elashoff, D., Ye, X., Turner, R. R., Giuliano, A. E., Hoon, D. S.B. (2006). Proteomic Profiling of Primary Breast Cancer Predicts Axillary Lymph Node Metastasis. Cancer Res. 66: 11825-11830 [Abstract] [Full Text]  
• Bolster, M. J., Bult, P., Schapers, R. F. M., Meijer, J. W. R., Strobbe, L. J. A., van Berlo, C. L. H., Klinkenbijl, J. H. G., Peer, P. G. M., Wobbes, T., Tjan-Heijnen, V. C. G. (2006). Differences in Sentinel Lymph Node Pathology Protocols Lead to Differences in Surgical Strategy in Breast Cancer Patients. Ann. Surg. Oncol. 13: 1466-1473 [Abstract] [Full Text]  
• Blancas, I, Garcia-Puche, J., Bermejo, B, Hanrahan, E., Monteagudo, C, Martinez-Agullo, A, Rouzier, R, Hennessy, B., Valero, V, Lluch, A (2006). Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol 17: 1644-1649 [Abstract] [Full Text]  
• Colleoni, M, Rotmensz, N, Peruzzotti, G, Maisonneuve, P, Orlando, L, Ghisini, R, Viale, G, Pruneri, G, Veronesi, P, Luini, A, Intra, M, Cardillo, A, Torrisi, R, Rocca, A, Goldhirsch, A (2006). Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 17: 1497-1503 [Abstract] [Full Text]  
• Chen, S. L., Iddings, D. M., Scheri, R. P., Bilchik, A. J. (2006). Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications. CA Cancer J Clin 56: 292-309 [Abstract] [Full Text]  
• Taback, B., Nguyen, P., Hansen, N., Edwards, G. K., Conway, K., Giuliano, A. E. (2006). Sentinel Lymph Node Biopsy for Local Recurrence of Breast Cancer After Breast-Conserving Therapy. Ann. Surg. Oncol. 13: 1099-1104 [Abstract] [Full Text]  
• Pater, J., Parulekar, W. (2006). Sentinel lymph node biopsy in early breast cancer: has its time come?. JNCI J Natl Cancer Inst 98: 568-569 [Full Text]  
• Mansel, R. E., Fallowfield, L., Kissin, M., Goyal, A., Newcombe, R. G., Dixon, J. M., Yiangou, C., Horgan, K., Bundred, N., Monypenny, I., England, D., Sibbering, M., Abdullah, T. I., Barr, L., Chetty, U., Sinnett, D. H., Fleissig, A., Clarke, D., Ell, P. J. (2006). Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.. JNCI J Natl Cancer Inst 98: 599-609 [Abstract] [Full Text]  
• Cox, C., White, L., Allred, N., Meyers, M., Dickson, D., Dupont, E., Cantor, A., Ly, Q., Dessureault, S., King, J., Nicosia, S., Vrcel, V., Diaz, N. (2006). Survival Outcomes in Node-Negative Breast Cancer Patients Evaluated With Complete Axillary Node Dissection Versus Sentinel Lymph Node Biopsy. Ann. Surg. Oncol. 13: 708-711 [Abstract] [Full Text]  
• Bleiweiss, I. J., Nagi, C. S., Jaffer, S. (2006). Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma. JCO 24: 2013-2018 [Abstract] [Full Text]  
• Houvenaeghel, G., Nos, C., Mignotte, H., Classe, J. M., Giard, S., Rouanet, P., Lorca, F. P., Jacquemier, J., Bardou, V. J. (2006). Micrometastases in Sentinel Lymph Node in a Multicentric Study: Predictive Factors of Nonsentinel Lymph Node Involvement--Groupe Des Chirurgiens De La Federation Des Centres De Lutte Contre Le Cancer. JCO 24: 1814-1822 [Abstract] [Full Text]  
• Wilke, L. G., McCall, L. M., Posther, K. E., Whitworth, P. W., Reintgen, D. S., Leitch, A. M., Gabram, S. G. A., Lucci, A., Cox, C. E., Hunt, K. K., Herndon, J. E. II, Giuliano, A. E. (2006). Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial. Ann. Surg. Oncol. 13: 491-500 [Abstract] [Full Text]  
• Abdul-Rasool, S, Kidson, S H, Panieri, E, Dent, D, Pillay, K, Hanekom, G S (2006). An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.. J. Clin. Pathol. 59: 289-297 [Abstract] [Full Text]  
• Nathanson, S. D., Slater, R., DeBruyn, D., Kapke, A., Linden, M. (2006). HER-2/neu Expression in Primary Breast Cancer With Sentinel Lymph Node Metastasis. Ann. Surg. Oncol. 13: 205-213 [Abstract] [Full Text]  
• Bouknight, R. R., Bradley, C. J., Luo, Z. (2006). Correlates of Return to Work for Breast Cancer Survivors. JCO 24: 345-353 [Abstract] [Full Text]  
• International Breast Cancer Study Group, (2006). Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93. JCO 24: 337-344 [Abstract] [Full Text]  
• Chou, H.-H., Chang, T.-C., Yen, T.-C., Ng, K.-K., Hsueh, S., Ma, S.-Y., Chang, C.-J., Huang, H.-J., Chao, A., Wu, T.-I, Jung, S.-M., Wu, Y.-C., Lin, C.-T., Huang, K.-G., Lai, C.-H. (2006). Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy. JCO 24: 123-128 [Abstract] [Full Text]  
• Rivers, A. K., Griffith, K. A., Hunt, K. K., Degnim, A. C., Sabel, M. S., Diehl, K. M., Cimmino, V. M., Chang, A. E., Lucas, P. C., Newman, L. A. (2006). Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node. Ann. Surg. Oncol. 13: 36-44 [Abstract] [Full Text]  
• Smidt, M. L., Kuster, D. M., van der Wilt, G. J., Thunnissen, F. B., Van Zee, K. J., Strobbe, L. J. A. (2005). Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands?. Ann. Surg. Oncol. 12: 1066-1072 [Abstract] [Full Text]  
• Davidson, N. E., Morrow, M., Kopans, D. B., Koerner, F. C. (2005). Case 35-2005 -- A 56-Year-Old Woman with Breast Cancer and Isolated Tumor Cells in a Sentinel Lymph Node. NEJM 353: 2177-2185 [Full Text]  
• Intra, M., Trifiro, G., Viale, G., Rotmensz, N., Gentilini, O. D., Soteldo, J., Galimberti, V., Veronesi, P., Luini, A., Paganelli, G., Veronesi, U. (2005). Second Biopsy of Axillary Sentinel Lymph Node for Reappearing Breast Cancer After Previous Sentinel Lymph Node Biopsy. Ann. Surg. Oncol. 12: 895-899 [Abstract] [Full Text]  
• Lyman, G. H., Giuliano, A. E., Somerfield, M. R., Benson, A. B. III, Bodurka, D. C., Burstein, H. J., Cochran, A. J., Cody, H. S. III, Edge, S. B., Galper, S., Hayman, J. A., Kim, T. Y., Perkins, C. L., Podoloff, D. A., Sivasubramaniam, V. H., Turner, R. R., Wahl, R., Weaver, D. L., Wolff, A. C., Winer, E. P. (2005). American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. JCO 23: 7703-7720 [Abstract] [Full Text]  
• Ryan, P. D., Kopans, D. B., Sgroi, D. C. (2005). Case 24-2005 - A 58-Year-Old Woman with Early-Stage Estrogen-Receptor-Positive Breast Cancer. NEJM 353: 617-622 [Full Text]  
• Purushotham, A. D., Upponi, S., Klevesath, M. B., Bobrow, L., Millar, K., Myles, J. P., Duffy, S. W. (2005). Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled Trial. JCO 23: 4312-4321 [Abstract] [Full Text]  
• Paganelli, G., Cremonesi, M., Ferrari, M., Trifiro, G., Gentilini, O., Luini, A. (2005). Reply to the Letter to the Editor on Safety of sentinel node biopsy in pregnant patients, by G. Dubernard et al. (Ann Oncol 2005; 16: 987). Ann Oncol 16: 987-988 [Full Text]  
• Kawase, K., DiMaio, D. J., Tucker, S. L., Buchholz, T. A., Ross, M. I., Feig, B. W., Kuerer, H. M., Meric-Bernstam, F., Babiera, G., Ames, F. C., Singletary, S. E., Hunt, K. K. (2005). Paget's Disease of the Breast: There Is a Role for Breast-Conserving Therapy. Ann. Surg. Oncol. 12: 391-397 [Abstract] [Full Text]  
• Mamounas, E. P., Brown, A., Anderson, S., Smith, R., Julian, T., Miller, B., Bear, H. D., Caldwell, C. B., Walker, A. P., Mikkelson, W. M., Stauffer, J. S., Robidoux, A., Theoret, H., Sovan, A., Fisher, B., Wickerham, D. L., Wolmark, N. (2005). Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27. JCO 23: 2694-2702 [Abstract] [Full Text]  
• Mamounas, E. P. (2005). Continuing Evolution in Breast Cancer Surgical Management. JCO 23: 1603-1606 [Full Text]  
• Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Mazzarol, G., Pruneri, G., Luini, A., Intra, M., Veronesi, P., Galimberti, V., Torrisi, R., Cardillo, A., Goldhirsch, A., Viale, G. (2005). Size of Breast Cancer Metastases in Axillary Lymph Nodes: Clinical Relevance of Minimal Lymph Node Involvement. JCO 23: 1379-1389 [Abstract] [Full Text]  
• Classe, J.-M., Fiche, M., Rousseau, C., Sagan, C., Dravet, F., Pioud, R., Lisbona, A., Ferrer, L., Campion, L., Resche, I., Curtet, C. (2005). Prospective Comparison of 3 {gamma}-Probes for Sentinel Lymph Node Detection in 200 Breast Cancer Patients. JNM 46: 395-399 [Abstract] [Full Text]  
• Luini, A., Gatti, G., Ballardini, B., Zurrida, S., Galimberti, V., Veronesi, P., Vento, A. R., Monti, S., Viale, G., Paganelli, G., Veronesi, U. (2005). Development of axillary surgery in breast cancer. Ann Oncol 16: 259-262 [Abstract] [Full Text]  
• Smidt, M. L., Janssen, C. M. M., Kuster, D. M., Bruggink, E. D. M., Strobbe, L. J. A. (2005). Axillary Recurrence After a Negative Sentinel Node Biopsy for Breast Cancer: Incidence and Clinical Significance. Ann. Surg. Oncol. 12: 29-33 [Abstract] [Full Text]  
• Maggard, M. A., Lane, K. E., O'Connell, J. B., Nanyakkara, D. D., Ko, C. Y. (2005). Beyond the Clinical Trials: How Often Is Sentinel Lymph Node Dissection Performed for Breast Cancer?. Ann. Surg. Oncol. 12: 41-47 [Abstract] [Full Text]  
• Cappelletti, V., Celio, L., Bajetta, E., Allevi, A., Longarini, R., Miodini, P., Villa, R., Fabbri, A., Mariani, L., Giovanazzi, R., Galante, E., Greco, M., Grazia Daidone, M. (2004). Prospective evaluation of estrogen receptor-{beta} in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients. Endocr Relat Cancer 11: 761-770 [Abstract] [Full Text]  
• Nagata, H., Arai, T., Soejima, Y., Suzuki, H., Ishii, H., Hibi, T. (2004). Limited Capability of Regional Lymph Nodes to Eradicate Metastatic Cancer Cells. Cancer Res. 64: 8239-8248 [Abstract] [Full Text]  
• Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Viale, G., Renne, G., Casadio, C., Veronesi, P., Intra, M., Torrisi, R., Goldhirsch, A. (2004). Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol 15: 1633-1639 [Abstract] [Full Text]  
• Rietman, J.S., Dijkstra, P.U., Geertzen, J.H. B., Baas, P., de Vries, J., Dolsma, W.V., Groothoff, J.W., Eisma, W.H., Hoekstra, H.J. (2004). Treatment-Related Upper Limb Morbidity 1 Year after Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection for Stage I or II Breast Cancer. Ann. Surg. Oncol. 11: 1018-1024 [Abstract] [Full Text]  
• Gentilini, O., Cremonesi, M., Trifiro, G., Ferrari, M., Baio, S. M., Caracciolo, M., Rossi, A., Smeets, A., Galimberti, V., Luini, A., Tosi, G., Paganelli, G. (2004). Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15: 1348-1351 [Abstract] [Full Text]  
• Imoto, S., Wada, N., Murakami, K., Hasebe, T., Ochiai, A., Ebihara, S. (2004). Prognosis of Breast Cancer Patients Treated with Sentinel Node Biopsy in Japan. Jpn J Clin Oncol 34: 452-456 [Abstract] [Full Text]  
• Intra, M., Rotmensz, N., Viale, G., Veronesi, U. (2004). Re: Trends in the Treatment of Ductal Carcinoma In Situ of the Breast. JNCI J Natl Cancer Inst 96: 1110-1111 [Full Text]  
• Peskin, G. W. (2004). The Best of the Best--2003. Arch Surg 139: 709-711 [Full Text]  
• Kell, M. R, Kerin, M. J (2004). Sentinel lymph node biopsy. BMJ 328: 1330-1331 [Full Text]  
• Tanaka, F., Takenaka, K., Oyanagi, H., Fujinaga, T., Otake, Y., Yanagihara, K., Ito, H., Wada, H. (2004). Skip mediastinal nodal metastases in non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 25: 1114-1120 [Abstract] [Full Text]  
• Wada, N., Imoto, S., Hasebe, T., Ochiai, A., Ebihara, S., Moriyama, N. (2004). Evaluation of Intraoperative Frozen Section Diagnosis of Sentinel Lymph Nodes in Breast Cancer. Jpn J Clin Oncol 34: 113-117 [Abstract] [Full Text]  
• Bude, R. O. (2004). Does Contrast-enhanced US Have Potential for Sentinel Lymph Node Detection?. Radiology 230: 603-604 [Full Text]  
• Dillehay, G. L., Krynyckyi, B. R., Kim, C. K. (2004). Invited Commentary * Authors' Response. RadioGraphics 24: 139-145 [Full Text]  
• McMasters, K. M. (2003). The Eternally Enigmatic Axilla: Further Controversy About Axillary Lymph Nodes in Breast Cancer. Ann. Surg. Oncol. 10: 1128-1130 [Full Text]  
• Cody, H. S. III (2003). Sentinel Lymph Node Biopsy for Breast Cancer: Does Anybody Not Need One?. Ann. Surg. Oncol. 10: 1131-1132 [Full Text]  
• Badwe, R. A., Thorat, M. A., Parmar, V. V., De Salvo, G. L., Del Bianco, P., Zavagno, G., Munster, A. M., McMasters, K. M., Veronesi, U., Maisonneuve, P., Krag, D., Ashikaga, T. (2003). Sentinel-Node Biopsy in Breast Cancer. NEJM 349: 1968-1971 [Full Text]  
• (2003). Sentinel-Node Biopsy: As Accurate as Axillary Dissection. JWatch Women's Health 2003: 7-7 [Full Text]  
• (2003). Outcomes After Sentinel-Node Biopsy in Breast Cancer. JWatch General 2003: 3-3 [Full Text]  
• Krag, D., Ashikaga, T. (2003). The Design of Trials Comparing Sentinel-Node Surgery and Axillary Resection. NEJM 349: 603-605 [Full Text]